Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

Side effects of Zepbound in clinical trials for obesity ... patients with a personal or family history of medullary thyroid cancer or in patients with multiple endocrine neoplasia syndrome type ...

Side effects of Zepbound The drug has also caused thyroid C-cell tumors in rats. Whether Zepbound would cause tumors, including medullary thyroid cancer, in humans is currently unknown.